·ÛºìÅ®ÀÉ & FSRH Introduce New Contraception Clinical Guideline
·ÛºìÅ®ÀÉ in collaboration with FSRH has launched a new comprehensive clinical guideline on contraception specifically adapted for Australia and Aotearoa New Zealand.
·ÛºìÅ®ÀÉ
The Royal Australian and New Zealand College of Obstetricians and Gynaecologists
The Royal Australian and New Zealand College of Obstetricians and Gynaecologists (·ÛºìÅ®ÀÉ, The College), in collaboration with the UK-based (FSRH), is proud to launch its newest clinical guideline, C-Gyn 3 Contraception (Signposting). C-Gyn 3 provides clinicians in Australia and Aotearoa New Zealand with recommendations to enable them to offer women in their care diverse contraceptive options and counsel them effectively to make an informed choice.
Produced by a Guideline Development Group, with oversight from ·ÛºìÅ®ÀÉ’s Women’s Health Committee, the new guideline signposts to FSRH’s high quality, evidence-based guidelines used widely in the UK and internationally.
·ÛºìÅ®ÀÉ has worked extensively with FSRH to summarise key recommendations and advice related to contraceptive choices and methods and where required, information has been adapted to ensure relevance and applicability for clinicians in Australia and Aotearoa New Zealand.
Importantly, this new guideline has been designed to improve accessibility and ease of use for busy specialists and GP’s working in different settings. The guideline replaces five individual statements on contraception topics and consolidates all information related to contraception into one central document.
The guideline is divided into 14 chapters and features a navigation page providing quick shortcuts to each section. Topics include:
Combined hormonal contraception
Intrauterine contraception
Progestogen-only pills, implants and injectables
Barrier methods
Fertility awareness methods
Quick starting contraception
Emergency contraception
Tubal ligation and vasectomy
The recommendations are holistic, and take into consideration indications, efficacy, side effects, potential contraindications and other key factors which are crucial in empowering women to make well informed decisions about their reproductive choices. The guideline also provides information clinicians may find useful when counselling women in specific population groups, such as women under 25 years of age and over 40, women after pregnancy, and women who may have higher body mass index (BMI).
This year-long inaugural partnership between ·ÛºìÅ®ÀÉ and FSRH exemplifies the benefits of leveraging collaborative opportunities with organisations working towards the shared objective of advancing women’s health.
The College would like to acknowledge the significant contributions of Professor Cindy Farquhar, Dean of Research and Policy, and the C-Gyn 3 Guideline Development Group chaired by Professor Kirsten Black, including Dr Catriona Melville, Dr Judith Gardiner, Associate Professor Ash Hanafy, Dr Frank Clark, Dr Richelle Douglas, Dr Anita Moss, Dr Joseph Gudex and Dr Divya Viswanathan.
Quotes Attributable to ·ÛºìÅ®ÀÉ:
Professor Kirsten Black, Chair- C-Gyn 3 Guideline Development Group: “As chair of ·ÛºìÅ®ÀÉ’s Sexual and Reproductive Health Committee and the C-Gyn 3 Guideline Development Group, I am delighted to see the release of these collaborative guidelines that will offer our Australian and New Zealand colleagues comprehensive evidence-based guidance for counselling and provision of contraception.â€
Professor Cindy Farquhar, ·ÛºìÅ®ÀÉ Dean of Research and Policy: “I am pleased to announce the publication of 14 guidelines on contraception topics for the use by ·ÛºìÅ®ÀÉ members. These guidelines were developed by the Faculty of Sexual and Reproductive Health in the UK. ·ÛºìÅ®ÀÉ has worked with the Faculty to adapt them to the Australia and Aotearoa New Zealand setting. The Faculty guidelines were chosen as they were comprehensive and assessed as high quality. We hope to continue to work together and will update these necessary.â€
Quotes Attributable to FSRH:
Dr Janet Barter, FSRH President: “We are thrilled to have worked with ·ÛºìÅ®ÀÉ to support the development of sexual and reproductive healthcare guidelines. The FSRH exists to enable healthcare professionals to provide the highest standards of care and we are proud that our collaboration with colleagues at ·ÛºìÅ®ÀÉ is supporting clinicians in Australia and New Zealand.â€
Dr Rebecca Strauss, Clinical Director, FSRH: “The FSRH develops guidelines using the best available evidence, clinical expertise and patient experience to support improvements to patient care and enable informed decisions on reproductive health choices. Working with ·ÛºìÅ®ÀÉ has been a fantastic opportunity to develop the positive impact and use of our guidelines outside of the UK and we have greatly valued working with the team at ·ÛºìÅ®ÀÉâ€.  
For member enquiries
·ÛºìÅ®ÀÉ Research & Policy/Women’s Health Team
womenshealth@ranzcog.edu.au
For media enquiries
Bec McPhee
Head of Advocacy & Communications
bmcphee@ranzcog.edu.au